- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Reconstructed Bladder in New Zealand
Total 567 results
-
AbbVieCompletedOveractive Detrusor | Neurogenic BladderUnited States
-
Processa PharmaceuticalsCompletedSolid Tumor | Metastatic Bladder CancerUnited States
-
EMD SeronoNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterCompletedKidney Cancer | Lung Cancer | Bladder CancerUnited States
-
Ascher-Walsh, Charles, M.D.CompletedVesicovaginal Fistula | Delivery of HealthcareUnited States
-
Boehringer IngelheimCompletedBladder, NeurogenicBelgium, Spain, United States, South Africa, Philippines, Italy, Korea, Republic of, Russian Federation, Germany, India, Brazil, Canada, Mexico, Ukraine
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedUrinary IncontinenceUnited States
-
AllerganTerminatedUrinary Incontinence | Urinary Bladder | OveractiveUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Italy, Netherlands, Norway, Poland, South Africa, United Kingdom
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; UConn Health; Adaptive Biotechnologies; MedGenomeCompleted
-
M.D. Anderson Cancer CenterRecruiting
-
National Cancer Institute (NCI)RecruitingStage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 | Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; University... and other collaboratorsRecruitingBladder CancerUnited States, Japan
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Astellas Pharma IncCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Czech Republic, Poland, Hungary, Belgium, Germany
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Ethicon Endo-SurgeryNovella Clinical; Data & Inference, Inc.CompletedOveractive BladderUnited States, Sweden, United Kingdom
-
Urovant Sciences GmbHCompletedOveractive Bladder With Urge Urinary IncontinenceUnited States
-
Cell GenesysUnknownCarcinoma, Transitional Cell | Bladder NeoplasmsUnited States, Canada
-
Targacept Inc.CompletedOveractive BladderUnited States
-
BioNTech US Inc.Bristol-Myers SquibbCompletedMelanoma | Carcinoma, Non-Small-Cell Lung | Lung Cancer | Urinary Bladder Cancer | Skin Cancer | Transitional Cell Carcinoma of the Bladder | Malignant Melanoma | Bladder TumorsUnited States
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedUrinary Incontinence, UrgeUnited States
-
AllerganCompletedUrinary Incontinence | Overactive Bladder With Urinary IncontinenceUnited States, Canada
-
Ferring PharmaceuticalsCompletedOveractive BladderUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrinary Bladder Neoplasms | Muscle-Invasive Bladder CancerRussian Federation, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Finland, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Portugal, Roman... and more
-
Watson PharmaceuticalsCompletedQuality of Life | Overactive Bladder | Urinary IncontinenceUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Locally Advanced Urothelial CarcinomaUnited States, Canada
-
UrigenCompletedPelvic Pain | Interstitial Cystitis | Bladder DiseasesUnited States
-
Tulane University Health Sciences CenterCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
UroGen Pharma Ltd.Active, not recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Spain, Lithuania, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Austria
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
zr Pharma & GmbHFoundation MedicineTerminatedBladder Cancer | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Muscle Invasive Bladder Cancer | Ureter Carcinoma | Renal Pelvis Carcinoma | Urinary Bladder Carcinoma | Urethra CarcinomaUnited States, Spain, France, Italy, Germany, United Kingdom
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedUrinary IncontinenceUnited States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder | Benign Prostatic HyperplasiaUnited States, Canada, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom
-
PfizerCompletedOveractive BladderCosta Rica, United States, Korea, Republic of, Germany, Slovakia, Ukraine, Belgium, Poland, Czechia
-
AllerganCompletedOveractive Bladder | Urinary IncontinenceIndia
-
Eisai Inc.H3 Biomedicine Inc.Withdrawn
-
PfizerCompletedOveractive BladderKorea, Republic of, United States, Denmark, Germany, Canada, Hungary, Poland, France, United Kingdom, Slovakia, Sweden, Mexico, Czech Republic, Finland, Italy, Lithuania, Argentina, Chile, Colombia, Egypt, Greece, Norway, Philippines, Russian Federation and more
-
Tyra Biosciences, IncRecruitingSolid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditionsAustralia, United States, France, Spain
-
Imbrium TherapeuticsPurdue Pharma LPRecruitingInterstitial Cystitis/Bladder Pain SyndromeUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedBladder CancerUnited States
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel
-
Matthew GalskyNovartis Pharmaceuticals; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma | Urothelial Carcinoma | Bladder CarcinomaUnited States
-
American Oriental Bioengineering, Inc.CompletedOveractive BladderUnited States
-
Urovant Sciences GmbHActive, not recruitingOveractive BladderUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
CG Oncology, Inc.RecruitingBladder Cancer | Urothelial Carcinoma | Urologic Cancer | Non Muscle Invasive Bladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); PfizerCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
AstraZenecaCompletedBladder Cancer | Urethra Cancer | Ureter Cancer | Renal Pelvis Cancer | Transitional Cell Bladder CancerUnited States, Spain, United Kingdom, Germany, Canada
-
SunovionPPD; ICON Clinical Research; Covance; Dainippon Sumitomo Pharma America; ClinPhone...CompletedOveractive Bladder Syndrome (OABS)France, United Kingdom, United States, Estonia, Germany, Latvia, Lithuania, Poland, Spain
-
PfizerCompletedOveractive BladderDenmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more